GlaxoSmithKline plc (LON:GSK)‘s stock had its “buy” rating reiterated by stock analysts at Citigroup Inc. in a report released on Monday.
GSK has been the topic of a number of other reports. Credit Suisse Group AG reissued a “neutral” rating and issued a GBX 1,800 ($22.49) price objective on shares of GlaxoSmithKline plc in a research report on Thursday, July 14th. S&P Global Inc. set a GBX 1,650 ($20.61) price objective on shares of GlaxoSmithKline plc and gave the company a “neutral” rating in a research report on Wednesday, July 27th. BNP Paribas reissued a “neutral” rating on shares of GlaxoSmithKline plc in a research report on Friday, July 29th. Goldman Sachs Group Inc. reissued a “buy” rating and issued a GBX 1,800 ($22.49) price objective on shares of GlaxoSmithKline plc in a research report on Thursday, October 27th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of GlaxoSmithKline plc in a research report on Tuesday, October 25th. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and nine have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of GBX 1,734.57 ($21.67).
GlaxoSmithKline plc (LON:GSK) traded up 1.15% on Monday, reaching GBX 1540.50. 7,445,723 shares of the company were exchanged. The stock’s market capitalization is GBX 74.96 billion. The stock has a 50-day moving average price of GBX 1,604.18 and a 200 day moving average price of GBX 1,586.69. GlaxoSmithKline plc has a 52 week low of GBX 1,277.25 and a 52 week high of GBX 1,745.56.
The business also recently disclosed a dividend, which will be paid on Thursday, January 12th. Investors of record on Thursday, November 3rd will be paid a GBX 19 ($0.24) dividend. This represents a dividend yield of 1.17%. The ex-dividend date of this dividend is Thursday, November 3rd.
In related news, insider Sir Andrew P. Witty sold 10,000 shares of the firm’s stock in a transaction dated Thursday, October 27th. The shares were sold at an average price of GBX 1,636 ($20.44), for a total value of £163,600 ($204,397.80). Also, insider Manvinder Singh Banga acquired 1,750 shares of GlaxoSmithKline plc stock in a transaction that occurred on Wednesday, October 26th. The stock was bought at an average price of GBX 1,643 ($20.53) per share, with a total value of £28,752.50 ($35,922.66).